Cargando…
Niclosamide Inhibits Cell Growth and Enhances Drug Sensitivity of Hepatocellular Carcinoma Cells via STAT3 Signaling Pathway
Aims: Hepatocellular carcinoma (HCC) is the sixth most common malignant tumor worldwide, with a high mortality rate at advanced stages. In this study, we investigated the effect of niclosamide on cell growth and drug sensitivity in human HCC and elucidated the underlying mechanism. Methods: Three hu...
Autores principales: | Wang, Chengzhi, Zhou, Xiaoqing, Xu, Hongjuan, Shi, Xiaqing, Zhao, Jinfeng, Yang, Manyi, Zhang, Lihua, Jin, Xin, Hu, Yu, Li, Xia, Xiao, Xiangcheng, Liao, Mingmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277621/ https://www.ncbi.nlm.nih.gov/pubmed/30519314 http://dx.doi.org/10.7150/jca.26948 |
Ejemplares similares
-
Nicotine Upregulates the Level of Mcl-1 through STAT3 in H1299 Cells
por: Zhou, Maojun, et al.
Publicado: (2020) -
Niclosamide: Beyond an antihelminthic drug
por: Chen, Wei, et al.
Publicado: (2018) -
Suppressing ERK Pathway Impairs Glycochenodeoxycholate-Mediated Survival and Drug-Resistance in Hepatocellular Carcinoma Cells
por: Li, Bingxin, et al.
Publicado: (2021) -
Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer
por: Shi, Lingyi, et al.
Publicado: (2017) -
Niclosamide suppresses T-cell acute lymphoblastic leukemia growth through activation of apoptosis and autophagy
por: Huang, Fang-Liang, et al.
Publicado: (2022)